 |
|
β-Adrenergic Blocking Agents in the Treatment of HypertensionChoices Based on Pharmacological Properties and Patient Characteristics
J. David Wallin, MD;
Sudhir V. Shah, MD
Arch Intern Med. 1987;147(4):654-659.
Abstract
• Drugs that block β-adrenergic receptors have become one of the most widely used classes of drugs to treat hypertension. This review puts the use of β-blockers as monotherapy for hypertension in perspective and provides reasons for choosing among the several β-blockers available. The major reasons for discriminating within this class of drugs are related to differences in concomitant clinical conditions, differences in patient responses, and intrinsic differences among the β-blockers. These differences relate to special properties such as β-agonist activity (intrinsic sympathomimetic activity), β1-selectivity, and concomitant  -blockade, as well as differences in side effect profiles, excretion characteristics, and length of action of the various drugs.
(Arch Intern Med 1987;147:654-659)
Author Affiliations
From the Section of Nephrology, Department of Medicine, Tulane University School of Medicine, and the Veterans Administration Medical Center, New Orleans.
Footnotes
Accepted for publication Sept 10, 1986.
Reprint requests to Section of Nephrology, Department of Medicine, Tulane University School of Medicine, 1430 Tulane Ave, New Orleans, LA 70112 (Dr Wallin).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Antihypertensives and the Risk of Serious Hypoglycemia in Older Persons Using Insulin or Sulfonylureas
Shorr et al.
JAMA 1997;278:40-43.
ABSTRACT
Can Physician Education Lower the Cost of Prescription Drugs? A Prospective, Controlled Trial
Frazier et al.
ANN INTERN MED 1991;115:116-121.
ABSTRACT
|
